{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T23:12:29Z","timestamp":1785798749363,"version":"3.56.0"},"reference-count":25,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T00:00:00Z","timestamp":1729123200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,8]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>We aimed to investigate mortality and prognostic factors in systemic sclerosis (SSc) patients with pulmonary hypertension (PH) with or without interstitial lung disease (ILD).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>The associations between mortality and demographics, transthoracic echocardiography, right heart catheterization (RHC), pulmonary functional parameters at baseline, and treatment modalities were evaluated.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Survival rates for PH-SSc patients (42 female, mean age 56.6 \u00b1 13.5, median follow-up 45 months) were 91% at the first year, 75% at 2 years, and 43.1% at 5 years. The majority of the deceased patients had PH + ILD (P = .007). The PH + ILD group had more diffuse skin involvement, anti-Scl-70, high C-reactive protein, low FVC, and lower DLCO. The deceased patients had higher estimated pulmonary arterial systolic pressure (PASP), low cardiac output, and FVC values. Median survival time was significantly better in patients on combined therapy. Mortality-related factors in the PH + ILD group were decreased initial FVC, high estimated PASP, low cardiac output, deteriorated functional class, and monotherapy.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>This is the first reported SSc-PH cohort from Turkey by a multidisciplinary team. PH is a severe complication of SSc with high mortality especially in patients with accompanying severe ILD.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/mr\/roae095","type":"journal-article","created":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T09:21:57Z","timestamp":1729156917000},"page":"478-483","source":"Crossref","is-referenced-by-count":4,"title":["Mortality and associated factors in patients with systemic sclerosis-associated pulmonary hypertension with and without interstitial lung disease: A long-term follow-up study"],"prefix":"10.1093","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8355-0176","authenticated-orcid":false,"given":"Shirkhan","family":"Amikishiyev","sequence":"first","affiliation":[{"name":"Division of Rheumatology, Istanbul Faculty of Medicine, Istanbul University , Fatih, Istanbul,","place":["Turkey"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasemin","family":"Yal\u00e7\u0131nkaya","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Istanbul Faculty of Medicine, Istanbul University , Fatih, Istanbul,","place":["Turkey"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konul","family":"Mammadova","sequence":"additional","affiliation":[{"name":"Department of Chest Diseases, Istanbul Faculty of Medicine, Istanbul University , Fatih, Istanbul,","place":["Turkey"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Numune","family":"Aliyeva","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Istanbul Faculty of Medicine, Istanbul University , Fatih, Istanbul,","place":["Turkey"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gorkem","family":"Durak","sequence":"additional","affiliation":[{"name":"Department of Radiology, \u0130stanbul Faculty of Medicine, \u0130stanbul University , Fatih, Istanbul,","place":["Turkey"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bahar","family":"Artim-Esen","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Istanbul Faculty of Medicine, Istanbul University , Fatih, Istanbul,","place":["Turkey"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmet","family":"G\u00fcl","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Istanbul Faculty of Medicine, Istanbul University , Fatih, Istanbul,","place":["Turkey"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmet Kaya","family":"Bilge","sequence":"additional","affiliation":[{"name":"Department of Cardiology, \u0130stanbul Faculty of Medicine, \u0130stanbul University , Fatih, Istanbul,","place":["Turkey"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gulfer","family":"Okumu\u015f","sequence":"additional","affiliation":[{"name":"Department of Chest Diseases, Istanbul Faculty of Medicine, Istanbul University , Fatih, Istanbul,","place":["Turkey"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murat","family":"Inanc","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Istanbul Faculty of Medicine, Istanbul University , Fatih, Istanbul,","place":["Turkey"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,10,17]]},"reference":[{"key":"2025050903163117700_R1","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S0140-6736(22)01692-0","article-title":"Systemic sclerosis","volume":"401","author":"Volkmann","year":"2023","journal-title":"Lancet"},{"key":"2025050903163117700_R2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ejim.2020.05.042","article-title":"Screening for pulmonary arterial hypertension in systemic sclerosis: a systematic literature review","volume":"78","author":"Bruni","year":"2020","journal-title":"Eur J Intern Med"},{"key":"2025050903163117700_R3","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0053-2021","article-title":"Pulmonary hypertension phenotypes in patients with systemic sclerosis","volume":"30","author":"Haque","year":"2021","journal-title":"Eur Respir Rev"},{"key":"2025050903163117700_R4","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1164\/rccm.200706-877OC","article-title":"Interstitial lung disease in systemic sclerosis: a simple staging system","volume":"177","author":"Goh","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"2025050903163117700_R5","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1002\/art.38029","article-title":"Survival and prognostic factors in systemic sclerosis\u2013associated pulmonary hypertension: a systematic review and meta-analysis","volume":"65","author":"Lefevre","year":"2013","journal-title":"Arthritis Rheum"},{"key":"2025050903163117700_R6","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-023-03059-x","article-title":"Clinical characteristics and survival of pulmonary arterial hypertension with or without interstitial lung disease in systemic sclerosis","volume":"25","author":"Fairley","year":"2023","journal-title":"Arthritis Res Ther"},{"key":"2025050903163117700_R7","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.chest.2023.08.013","article-title":"Impact of systemic sclerosis-associated interstitial lung disease with and without pulmonary hypertension on survival: a large cohort study of the German network for systemic sclerosis","volume":"165","author":"Moinzadeh","year":"2024","journal-title":"Chest"},{"key":"2025050903163117700_R8","first-page":"577","article-title":"Preliminary criteria for the classification of systemic sclerosis (scleroderma)","volume":"13","author":"Masi","year":"1980","journal-title":"Arthritis Rheum"},{"key":"2025050903163117700_R9","article-title":"Primary pulmonary hypertension: report on a WHO meeting, Geneva","author":"Hatano","year":"1976"},{"key":"2025050903163117700_R10","article-title":"Scleroderma (systemic sclerosis): classification, subsets and pathogenesis","volume":"15","author":"SSc","year":"1988","journal-title":"J Rheumatol"},{"key":"2025050903163117700_R11","first-page":"1281","article-title":"Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis","volume":"22","author":"Clements","year":"1995","journal-title":"J Rheumatol"},{"key":"2025050903163117700_R12","doi-asserted-by":"crossref","first-page":"S84","DOI":"10.1513\/AnnalsATS.201610-788FR","article-title":"Cardiopulmonary exercise testing in pulmonary hypertension","volume":"14","author":"Weatherald","year":"2017","journal-title":"Ann Am Thorac Soc"},{"key":"2025050903163117700_R13","doi-asserted-by":"crossref","first-page":"92","DOI":"10.2340\/1650197719702239298","article-title":"Perceived exertion as an indicator of somatic stress","volume":"2","author":"Borg","year":"1970","journal-title":"Scand J Rehabil Med"},{"key":"2025050903163117700_R14","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02311-2021","article-title":"COMPERA 2.0: a refined four-stratum risk assessment model for pulmonary arterial hypertension","volume":"60","author":"Hoeper","year":"2022","journal-title":"Eur Respir J"},{"key":"2025050903163117700_R15","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02419-2021","article-title":"External validation of a refined four-stratum risk assessment score from the French pulmonary hypertension registry","volume":"59","author":"Boucly","year":"2022","journal-title":"Eur Respir J"},{"key":"2025050903163117700_R16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0197112","article-title":"Clinical phenotypes and survival of pre-capillary pulmonary hypertension in systemic sclerosis","volume":"13","author":"Launay","year":"2018","journal-title":"PLoS One"},{"key":"2025050903163117700_R17","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1093\/rheumatology\/keac512","article-title":"Survival and prognostic factors from a multicentre large cohort of unselected Italian systemic sclerosis patients","volume":"62","author":"Cacciapaglia","year":"2023","journal-title":"Rheumatology (Oxford)"},{"key":"2025050903163117700_R18","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/s41584-022-00765-9","article-title":"Skin involvement in early diffuse cutaneous systemic sclerosis: an unmet clinical need","volume":"18","author":"Herrick","year":"2022","journal-title":"Nat Rev Rheumatol"},{"key":"2025050903163117700_R19","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1002\/art.39490","article-title":"Derivation and external validation of a prediction rule for five-year mortality in patients with early diffuse cutaneous systemic sclerosis","volume":"68","author":"Domsic","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"2025050903163117700_R20","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1093\/eurheartj\/ehac237","article-title":"2022 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: developed by the task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS). Endorsed by the International Society for Heart and Lung Transplantation (ISHLT) and the European Reference Network on rare respiratory diseases (ERN-LUNG)","volume":"43","author":"Humbert","year":"2022","journal-title":"Eur Heart J"},{"key":"2025050903163117700_R21","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01197-2017","article-title":"Incidence of pulmonary hypertension and determining factors in patients with systemic sclerosis","volume":"51","author":"Coghlan","year":"2018","journal-title":"Eur Respir J"},{"key":"2025050903163117700_R22","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1002\/art.37838","article-title":"Borderline mean pulmonary artery pressure in patients with systemic sclerosis: transpulmonary gradient predicts risk of developing pulmonary hypertension","volume":"65","author":"Valerio","year":"2013","journal-title":"Arthritis Rheum"},{"key":"2025050903163117700_R23","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1002\/art.40814","article-title":"Reduced right ventricular output reserve in patients with systemic sclerosis and mildly elevated pulmonary artery pressure","volume":"71","author":"Nagel","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"2025050903163117700_R24","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1056\/NEJMoa2008470","article-title":"Inhaled treprostinil in pulmonary hypertension due to interstitial lung disease","volume":"384","author":"Waxman","year":"2021","journal-title":"N Engl J Med"},{"key":"2025050903163117700_R25","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01483-2021","article-title":"Pulmonary vascular resistance predicts mortality in patients with pulmonary hypertension associated with interstitial lung disease: results from the COMPERA registry","volume":"58","author":"Olsson","year":"2021","journal-title":"Eur Respir J"}],"container-title":["Modern Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/mr\/advance-article-pdf\/doi\/10.1093\/mr\/roae095\/60242366\/roae095.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mr\/article-pdf\/35\/3\/478\/60242366\/roae095.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mr\/article-pdf\/35\/3\/478\/60242366\/roae095.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T07:16:44Z","timestamp":1746775004000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mr\/article\/35\/3\/478\/7824571"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,17]]},"references-count":25,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,10,17]]},"published-print":{"date-parts":[[2025,4,8]]}},"URL":"https:\/\/doi.org\/10.1093\/mr\/roae095","relation":{},"ISSN":["1439-7595","1439-7609"],"issn-type":[{"value":"1439-7595","type":"print"},{"value":"1439-7609","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,5]]},"published":{"date-parts":[[2024,10,17]]}}}